Treatment of smaller coronary vessels with XIENCE V everolimus-eluting stents in real-world patients: 1-year clinical outcomes from the XIENCE V USA study

A North American population's predictors of early clopidogrel discontinuation after drug-eluting stent implantation Ana Laynez, Michael A. Gaglia, Jr., Kohei Wakabayashi, Rafael Romaguera, Gabriel Maluenda, Gabriel Sardi, Itsik Ben-Dor, Manuel A. Gonzalez, Michael Mahmoudi, Camille Hauville, Rebecca Torguson, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Joseph Lindsay, Augusto D. Pichard, Ron Waksman Washington Hospital Center, Washington, DC